BMYx — Bristol-Myers Squibb xStock
24h +0.89%30d —as of Aug 25, 2026
Tokenized exposure to Bristol-Myers Squibb, settled on-chain.
Verified disclosure data
Search assets, issuers, categories and contract addresses
Tokenized exposure to Bristol-Myers Squibb, settled on-chain.
Bristol-Myers Squibb xStock is a backed xstock tracking Bristol-Myers Squibb. It is an ERC-20 on Ethereum, so it can be held in any wallet the issuer permits and composed into on-chain applications. Prism verified the contract directly on-chain: it reports the symbol its issuer publishes and a readable supply.
Bristol-Myers Squibb xStock gives economic exposure to Bristol-Myers Squibb without holding the security itself. The contract was verified on-chain by Prism. Reference price is the underlying's last close (BMY); the token can trade away from it, and Prism quotes every trade live before you sign.
Generated from issuer disclosures and reviewed against the sources listed below. Not investment advice.
Addresses shown only where independently confirmed against explorers and issuer documentation. Holder and transfer analytics are available via the linked explorers.
No. This is a tokenized instrument giving economic exposure. Rights are defined by the issuer's own terms, not by share ownership.
Prism called the contract directly on its chain and confirmed it reports the symbol and decimals its issuer publishes, with a readable non-zero supply. The full record is on the verification page.
Prism quotes every trade live at the moment you ask. If no route exists at your size you will see that before signing rather than after.
